ABCL
Price
$2.44
Change
+$0.07 (+2.95%)
Updated
Jun 6 closing price
Capitalization
705.92M
65 days until earnings call
CDXS
Price
$2.37
Change
+$0.11 (+4.87%)
Updated
Jun 6 closing price
Capitalization
187.23M
53 days until earnings call
Interact to see
Advertisement

ABCL vs CDXS

Header iconABCL vs CDXS Comparison
Open Charts ABCL vs CDXSBanner chart's image
AbCellera Biologics
Price$2.44
Change+$0.07 (+2.95%)
Volume$3.8M
Capitalization705.92M
Codexis
Price$2.37
Change+$0.11 (+4.87%)
Volume$698.67K
Capitalization187.23M
ABCL vs CDXS Comparison Chart
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CDXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. CDXS commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Buy and CDXS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (ABCL: $2.04 vs. CDXS: $2.33)
Brand notoriety: ABCL and CDXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 62% vs. CDXS: 67%
Market capitalization -- ABCL: $705.92M vs. CDXS: $187.23M
ABCL [@Biotechnology] is valued at $705.92M. CDXS’s [@Biotechnology] market capitalization is $187.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileCDXS’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • CDXS’s FA Score: 0 green, 5 red.
According to our system of comparison, CDXS is a better buy in the long-term than ABCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 5 TA indicator(s) are bullish while CDXS’s TA Score has 3 bullish TA indicator(s).

  • ABCL’s TA Score: 5 bullish, 5 bearish.
  • CDXS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ABCL is a better buy in the short-term than CDXS.

Price Growth

ABCL (@Biotechnology) experienced а +2.51% price change this week, while CDXS (@Biotechnology) price change was -0.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 12, 2025.

CDXS is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($706M) has a higher market cap than CDXS($187M). ABCL YTD gains are higher at: -30.375 vs. CDXS (-51.153). CDXS has higher annual earnings (EBITDA): -53.41M vs. ABCL (-204.15M). ABCL has more cash in the bank: 626M vs. CDXS (73.5M). CDXS has less debt than ABCL: CDXS (59.9M) vs ABCL (65.4M). CDXS has higher revenues than ABCL: CDXS (59.3M) vs ABCL (28.8M).
ABCLCDXSABCL / CDXS
Capitalization706M187M378%
EBITDA-204.15M-53.41M382%
Gain YTD-30.375-51.15359%
P/E RatioN/AN/A-
Revenue28.8M59.3M49%
Total Cash626M73.5M852%
Total Debt65.4M59.9M109%
FUNDAMENTALS RATINGS
CDXS: Fundamental Ratings
CDXS
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLCDXS
RSI
ODDS (%)
Bullish Trend 12 days ago
85%
N/A
Stochastic
ODDS (%)
Bullish Trend 12 days ago
78%
Bearish Trend 12 days ago
85%
Momentum
ODDS (%)
Bearish Trend 12 days ago
85%
Bearish Trend 12 days ago
82%
MACD
ODDS (%)
Bullish Trend 12 days ago
78%
N/A
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 12 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
88%
Bullish Trend 12 days ago
83%
Advances
ODDS (%)
Bullish Trend 12 days ago
76%
Bullish Trend 13 days ago
85%
Declines
ODDS (%)
Bearish Trend 25 days ago
86%
Bearish Trend 21 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
73%
Bearish Trend 12 days ago
90%
Aroon
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CDXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+3.03%
CRSP - ABCL
61%
Loosely correlated
-0.92%
ABSI - ABCL
59%
Loosely correlated
+0.74%
RXRX - ABCL
59%
Loosely correlated
+0.11%
NTLA - ABCL
57%
Loosely correlated
+3.59%
BEAM - ABCL
57%
Loosely correlated
-0.88%
More

CDXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDXS has been loosely correlated with DNLI. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CDXS jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDXS
1D Price
Change %
CDXS100%
-8.63%
DNLI - CDXS
53%
Loosely correlated
-1.29%
PRAX - CDXS
48%
Loosely correlated
+2.58%
ABCL - CDXS
46%
Loosely correlated
+3.03%
BEAM - CDXS
46%
Loosely correlated
-0.88%
CRSP - CDXS
44%
Loosely correlated
-0.92%
More